Clinical Trial Update: Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer

View source ↗

Summary

This clinical trial update reports on the assessment of complete pathologic response after neoadjuvant chemotherapy in breast cancer. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: TN ER-/PR-/HER2- Breast Cancer, Triple Negative Breast Cancer | Status: COMPLETED